Clinical Trials Browser

Phase NA × Digestive System Neoplasms × 90 days × Clear all

Carcinoma, Colonic Diseases, Digestive System Diseases, Digestive System Neoplasms, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasm Metastasis, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Colorectal Neoplasms, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT06794073 2026-05-11

Efficacy and Safety of Multimodal Ablation Combined With PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of Unresectable Primary Hepatocellular Carcinoma: A Single-Arm, Single-Center Clinical Study

Phase NA Recruiting

17 enrolled

Gastrointestinal

Adenocarcinoma, Digestive System Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasms, Glandular and Epithelial

NCT04929015 2026-05-04

Peritoneal Carcinomatosis Leveraging ctDNA Guided Treatment in GI Cancer Study (PERICLES Study)

Phase NA Suspended

30 enrolled

GastrointestinalGynecologic

Digestive System Neoplasms, Carcinoma, Hepatocellular, Peritoneal Neoplasms

NCT04084249 2026-04-29

ctDNA-guided Surveillance for Stage III CRC, a Randomized Intervention Trial

Phase NA Active not recruiting

359 enrolled

Gastrointestinal

Colonic Diseases, Colonic Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Neoplasms, Rectal Diseases, Rectal Neoplasms, Colorectal Neoplasms

NCT03221335 2026-03-20

EUS-guided RFA for Solid Abdominal Neoplasms

Phase NA Recruiting

30 enrolled

GastrointestinalGenitourinary

Carcinoma, Renal Cell, Digestive System Neoplasms

Clinical Trials

INDIGO

Efficacy and Safety of Multimodal Ablation Combined With PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of Unresectable Primary Hepatocellular Carcinoma: A Single-Arm, Single-Center Clinical Study

Peritoneal Carcinomatosis Leveraging ctDNA Guided Treatment in GI Cancer Study (PERICLES Study)

ctDNA-guided Surveillance for Stage III CRC, a Randomized Intervention Trial

EUS-guided RFA for Solid Abdominal Neoplasms